KLDO (Kaleido Biosciences) Other Current Liabilities: $0.35 Mil (As of Dec. 2021)


What is Kaleido Biosciences Other Current Liabilities?

Kaleido Biosciences KLDO Other Current Liabilities is $0.35 Mil as of Dec. 2021.

Kaleido Biosciences's other current liabilities for the quarter that ended in Dec. 2021 was $0.35 Mil.

Kaleido Biosciences's quarterly other current liabilities declined from Jun. 2021 ($0.70 Mil) to Sep. 2021 ($0.49 Mil) and declined from Sep. 2021 ($0.49 Mil) to Dec. 2021 ($0.35 Mil).

Kaleido Biosciences's annual other current liabilities declined from Dec. 2019 ($1.21 Mil) to Dec. 2020 ($0.78 Mil) and declined from Dec. 2020 ($0.78 Mil) to Dec. 2021 ($0.35 Mil).

Kaleido Biosciences Other Current Liabilities Related Terms

Kaleido Biosciences Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Kaleido Biosciences's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kaleido Biosciences Other Current Liabilities Chart

Kaleido Biosciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Other Current Liabilities
Get a 7-Day Free Trial 0.27 0.42 1.21 0.78 0.35

Kaleido Biosciences Quarterly Data
Dec16 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.78 1.02 0.70 0.49 0.35

Kaleido Biosciences Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of $0.35 Mil mean?
Kaleido Biosciences (KLDO) has a Other Current Liabilities of $0.35 Mil as of Dec. 2021. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Kaleido Biosciences.
Is Kaleido Biosciences' Other Current Liabilities too high?
Kaleido Biosciences' current Other Current Liabilities is $0.35 Mil.
How does Kaleido Biosciences' Other Current Liabilities compare to NPTX and GSTC?
Kaleido Biosciences' Other Current Liabilities of $0.35 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Biotechnology company?
A good Other Current Liabilities depends on the Biotechnology industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Kaleido Biosciences. Kaleido Biosciences's current Other Current Liabilities is $0.35 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kaleido Biosciences stock overvalued right now?
Kaleido Biosciences (KLDO) has a current Other Current Liabilities of $0.35 Mil. The current Other Current Liabilities is $0.35 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Kaleido Biosciences (KLDO), the current Other Current Liabilities is $0.35 Mil as of Dec. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kaleido Biosciences Business Description

Address 65 Hayden Avenue, Lexington, MA, USA, 02421
Kaleido Biosciences Inc is a clinical-stage healthcare company. It is focused on leveraging the potential of the microbiome organ to treat disease and improve human health. Its product candidates are Microbiome Metabolic Therapies, or MMTs, which are designed to modulate the metabolic output and profile of the microbiome.